Scientific publications

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease. Scientific Publication

Jan 29, 2024 | Magazine: Annals of Oncology

J A Ledermann  1 , X Matias-Guiu  2 , F Amant  3 , N Concin  4 , B Davidson  5 , C Fotopoulou  6 , A González-Martin  7 , C Gourley  8 , A Leary  9 , D Lorusso  10 , S Banerjee  11 , L Chiva  12 , D Cibula  13 , N Colombo  14 , S Croce  15 , A G Eriksson  16 , C Falandry  17 , D Fischerova  13 , P Harter  18 , F Joly  19 , C Lazaro  20 , C Lok  21 , S Mahner  22 , F Marmé  23 , C Marth  24 , W G McCluggage  25 , I A McNeish  6 , P Morice  26 , S Nicum  27 , A Oaknin  28 , J A Pérez-Fidalgo  29 , S Pignata  30 , P T Ramirez  31 , I Ray-Coquard  32 , I Romero  33 , G Scambia  10 , J Sehouli  34 , R Shapira-Frommer  35 , S Sundar  36 , D S P Tan  37 , C Taskiran  38 , W J van Driel  21 , I Vergote  39 , F Planchamp  40 , C Sessa  41 , A Fagotti  42


Abstract

The European Society of Gynaecological Oncology, the European Society for Medical Oncology (ESMO) and the European Society of Pathology held a consensus conference (CC) on ovarian cancer on 15-16 June 2022 in Valencia, Spain.

The CC panel included 44 experts in the management of ovarian cancer and pathology, an ESMO scientific advisor and a methodologist. The aim was to discuss new or contentious topics and develop recommendations to improve and harmonise the management of patients with ovarian cancer.

Eighteen questions were identified for discussion under four main topics: (i) pathology and molecular biology, (ii) early-stage disease and pelvic mass in pregnancy, (iii) advanced stage (including older/frail patients) and (iv) recurrent disease. The panel was divided into four working groups (WGs) to each address questions relating to one of the four topics outlined above, based on their expertise.

Relevant scientific literature was reviewed in advance. Recommendations were developed by the WGs and then presented to the entire panel for further discussion and amendment before voting. This manuscript focuses on the recommendation statements that reached a consensus, their voting results and a summary of evidence supporting each recommendation.

CITATION  Ann Oncol. 2024 Jan 29:S0923-7534(23)05103-7.doi: 10.1016/j.annonc.2023.11.015